Baidu
map

JAMA:心血管疾病风险因子或致男性外周动脉疾病风险增加

2013-05-06 T.Shen 生物谷

2012年10月24日来自国际杂志JAMA的一项针对45000名男性的研究揭示了,超过20年接触和吸烟、高血压、高胆固醇以及II型糖尿病相关的风险因子的男性,其或者更容易引发外周动脉疾病(Peripheral artery disease,PAD)。 PAD是一种由于动脉狭窄堵塞引发的动脉粥样硬化综合症,其在美国影响着800至1000万人的正常生活,而且其可以增加患者患心脑血管疾病,甚至引发患者

2012年10月24日来自国际杂志JAMA的一项针对45000名男性的研究揭示了,超过20年接触和吸烟、高血压、高胆固醇以及II型糖尿病相关的风险因子的男性,其或者更容易引发外周动脉疾病(Peripheral artery disease,PAD)。

PAD是一种由于动脉狭窄堵塞引发的动脉粥样硬化综合症,其在美国影响着800至1000万人的正常生活,而且其可以增加患者患心脑血管疾病,甚至引发患者死亡。如今针对PAD的治疗并不奏效。

来自哈佛医学院等处的研究者开展了一项研究,来评估积累四项风险因子(吸烟、高血压、高胆固醇以及II型糖尿病)的男性患PAD的风险情况。研究者跟踪调查研究了44985名男性参与者。在接下来的24.2年里,有537例发生了PAD疾病。研究者发现,四种风险因子,都可以独立和PAD发病相关。不考虑时间因素,相比无风险因子的男性,所有携带一种风险因子的男性发生PAD的风险明显升高。然而附加一种风险因子,即两种就会使得PAD发病风险加倍。没有四种风险因子的男性,其发生PAD的风险会降低77%,而在96%的PAD患者病例中,至少都会有1种到4种风险因子。

PAD的发病风险更容易增加II型糖尿病和高胆固醇血症的持续时间,总的来说,四种风险因子:抽烟、高血压、高胆固醇以及II型糖尿病在临床上可以独立影响患者PAD的发病。

心血管相关的拓展阅读:

Associations Between Conventional Cardiovascular Risk Factors and Risk of Peripheral Artery Disease in Men

Context Previous studies have examined the associations of individual clinical risk factors with risk of peripheral artery disease (PAD), but the combined effects of these risk factors are largely unknown. Objective To estimate the degree to which the 4 conventional cardiovascular risk factors of smoking, hypertension, hypercholesterolemia, and type 2 diabetes are associated with the risk of PAD among men. Design, Setting, and Participants Prospective study of 44 985 men in the United States without a history of cardiovascular disease at baseline in 1986; participants in the Health Professionals Follow-up Study were followed up for 25 years until January 2011. The presence of risk factors was updated biennially during follow-up. Main Outcome Measure Clinically significant PAD defined as limb amputation or revascularization, angiogram reporting vascular obstruction of 50% or greater, ankle-brachial index of less than 0.90, or physician-diagnosed PAD. Results During a median follow-up of 24.2 years (interquartile range, 20.8-24.7 years), there were 537 cases of incident PAD. Each risk factor was significantly and independently associated with a higher risk of PAD after adjustment for the other 3 risk factors and confounders. The age-adjusted incidence rates were 9 (95% CI, 6-14) cases/100 000 person-years (n = 19 incident cases) for 0 risk factors, 23 (95% CI, 18-28) cases/100 000 person-years (n = 99 incident cases) for 1 risk factor, 47 (95% CI, 39-56) cases/100 000 person-years (n = 176 incident cases) for 2 risk factors, 92 (95% CI, 76-111) cases/100 000 person-years (n = 180 incident cases) for 3 risk factors, and 186 (95% CI, 141-246) cases/100 000 person-years (n = 63 incident cases) for 4 risk factors. The multivariable-adjusted hazard ratio for each additional risk factor was 2.06 (95% CI, 1.88-2.26). Men without any of the 4 risk factors had a hazard ratio of PAD of 0.23 (95% CI, 0.14-0.36) compared with all other men in the cohort. In 96% of PAD cases (95% CI, 94%-98%), at least 1 of the 4 risk factors was present at the time of PAD diagnosis. The population-attributable risk associated with these 4 risk factors was 75% (95% CI, 64%-87%). The absolute incidence of PAD among men with all 4 risk factors was 3.5/1000 person-years. Conclusion Among men in this cohort, smoking, hypertension, hypercholesterolemia, and type 2 diabetes account for the majority of risk associated with development of clinically significant PAD.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1799502, encodeId=608a1e99502e6, content=<a href='/topic/show?id=16fae074736' target=_blank style='color:#2F92EE;'>#疾病风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70747, encryptionId=16fae074736, topicName=疾病风险因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Sat Nov 16 13:55:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472922, encodeId=8ff514e29229b, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497779, encodeId=bd7b149e7792f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529245, encodeId=011715292457d, content=<a href='/topic/show?id=6eb91008e03b' target=_blank style='color:#2F92EE;'>#风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100870, encryptionId=6eb91008e03b, topicName=风险因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2d411920658, createdName=cenghis, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593254, encodeId=0cc015932546c, content=<a href='/topic/show?id=8d1342e95fa' target=_blank style='color:#2F92EE;'>#外周动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42795, encryptionId=8d1342e95fa, topicName=外周动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b27818121614, createdName=wujh_7312825, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1799502, encodeId=608a1e99502e6, content=<a href='/topic/show?id=16fae074736' target=_blank style='color:#2F92EE;'>#疾病风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70747, encryptionId=16fae074736, topicName=疾病风险因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Sat Nov 16 13:55:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472922, encodeId=8ff514e29229b, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497779, encodeId=bd7b149e7792f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529245, encodeId=011715292457d, content=<a href='/topic/show?id=6eb91008e03b' target=_blank style='color:#2F92EE;'>#风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100870, encryptionId=6eb91008e03b, topicName=风险因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2d411920658, createdName=cenghis, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593254, encodeId=0cc015932546c, content=<a href='/topic/show?id=8d1342e95fa' target=_blank style='color:#2F92EE;'>#外周动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42795, encryptionId=8d1342e95fa, topicName=外周动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b27818121614, createdName=wujh_7312825, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1799502, encodeId=608a1e99502e6, content=<a href='/topic/show?id=16fae074736' target=_blank style='color:#2F92EE;'>#疾病风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70747, encryptionId=16fae074736, topicName=疾病风险因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Sat Nov 16 13:55:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472922, encodeId=8ff514e29229b, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497779, encodeId=bd7b149e7792f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529245, encodeId=011715292457d, content=<a href='/topic/show?id=6eb91008e03b' target=_blank style='color:#2F92EE;'>#风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100870, encryptionId=6eb91008e03b, topicName=风险因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2d411920658, createdName=cenghis, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593254, encodeId=0cc015932546c, content=<a href='/topic/show?id=8d1342e95fa' target=_blank style='color:#2F92EE;'>#外周动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42795, encryptionId=8d1342e95fa, topicName=外周动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b27818121614, createdName=wujh_7312825, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1799502, encodeId=608a1e99502e6, content=<a href='/topic/show?id=16fae074736' target=_blank style='color:#2F92EE;'>#疾病风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70747, encryptionId=16fae074736, topicName=疾病风险因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Sat Nov 16 13:55:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472922, encodeId=8ff514e29229b, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497779, encodeId=bd7b149e7792f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529245, encodeId=011715292457d, content=<a href='/topic/show?id=6eb91008e03b' target=_blank style='color:#2F92EE;'>#风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100870, encryptionId=6eb91008e03b, topicName=风险因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2d411920658, createdName=cenghis, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593254, encodeId=0cc015932546c, content=<a href='/topic/show?id=8d1342e95fa' target=_blank style='color:#2F92EE;'>#外周动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42795, encryptionId=8d1342e95fa, topicName=外周动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b27818121614, createdName=wujh_7312825, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1799502, encodeId=608a1e99502e6, content=<a href='/topic/show?id=16fae074736' target=_blank style='color:#2F92EE;'>#疾病风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70747, encryptionId=16fae074736, topicName=疾病风险因子)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eaf430, createdName=bsmagic9132, createdTime=Sat Nov 16 13:55:00 CST 2013, time=2013-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1472922, encodeId=8ff514e29229b, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1497779, encodeId=bd7b149e7792f, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1529245, encodeId=011715292457d, content=<a href='/topic/show?id=6eb91008e03b' target=_blank style='color:#2F92EE;'>#风险因子#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=100870, encryptionId=6eb91008e03b, topicName=风险因子)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2d411920658, createdName=cenghis, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1593254, encodeId=0cc015932546c, content=<a href='/topic/show?id=8d1342e95fa' target=_blank style='color:#2F92EE;'>#外周动脉#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42795, encryptionId=8d1342e95fa, topicName=外周动脉)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b27818121614, createdName=wujh_7312825, createdTime=Wed May 08 14:55:00 CST 2013, time=2013-05-08, status=1, ipAttribution=)]

相关资讯

Am. J. Epidemiol:狼疮患者泼尼松用量应小于10mg/d

  纽约——约翰霍普金斯大学的Michelle Petri博士在纽约大学主办的会议上报告称,泼尼松日剂量>10 mg可使系统性红斑狼疮(SLE)患者的心血管事件(CVE)风险加倍。他建议,应尽最大努力确保红斑狼疮患者泼尼松用量<10 mg/d的临界值。   在这项旨在探索可能增加SLE患者CVE风险的因素的观察性队列研究中,研究者分析了霍普金斯狼疮队列中1,874例SLE患者的资料,该队列

Diabetes Care:强化降糖心血管益处仍未显现

  在一项研究中,接受为期9个月强化降糖治疗的老年2型糖尿病患者,其脂联素、脂质、甘油三酯水平有所改善。强化降糖仍未能显示出对患者心血管结局的改善。  原始出处: Koska J, Saremi A, Bahn G, Yamashita S, Reaven PD; for the Veterans Affairs Diabetes Trial Investigators.The Effect

JACC:我国学者发明无创去肾交感神经术

  体外高强度聚焦超声引导下的无创去肾交感神经术首次在狗模型中获得成功   在顽固性高血压治疗领域,经导管射频消融去肾交感神经术(RSD)可以说是划时代之创举,Symplicity HTN 研究证实了经导管射频消融RSD的安全性和有效性。   近日,我国重庆医科大学附属第二医院心内科黄晶教授等发表文章,宣布首次在狗模型上成功完成体外高强度聚焦超声(HIFU)引导下的无创RS

JAMA:高灵敏度cTnT与二级预防的心血管事件相关

    最新研究表明,稳定性冠脉心脏病门诊患者的高敏心肌肌钙蛋白T(hs-cTnT)水平与继发性心血管事件风险升高呈独立相关性。    Alexis Beatty博士(旧金山加州大学)和他的同事发表在2013年4月8日的《JAMA:内科学》上)研究表明,hs-cTnT水平可对不能被现有心血管疾病严重程度指标衡量的风险因素进行量化。数据来自

强化降糖心血管益处仍未显现

  在一项研究中,接受为期9个月强化降糖治疗的老年2型糖尿病患者,其脂联素、脂质、甘油三酯水平有所改善。强化降糖仍未能显示出对患者心血管结局的改善。   来源:The Effect of Intensive Glucose Lowering on Lipoprotein Particle Profil

Diabetes Care:糖尿病患者早期控制血压可降低心血管事件发生

为了评估早期进行血压控制对伴新发高血压的糖尿病患者主要心血管事件的影响,来自美国明尼阿波里斯市卫生伙伴研究基金会的Patrick J Oconnor博士及其团队进行了一项研究,该研究结果发表在2013年2月的美国《糖尿病治疗》(Diabetes Care)杂志上。该研究发现对新发高血压的糖尿病患者积极行血压控制可带来显著的短期临床获益。该研究中,受试者包括15,665例新近诊断高血压的糖尿病患者,

Baidu
map
Baidu
map
Baidu
map